Abstract
Background: Rhinocerebral mucormycosis is a rare, rapidly progressive and potentially lethal disease almost exclusively affecting immunocompromised hosts or patients with metabolic disorders, such as poorly controlled diabetes mellitus.
Methods: This work is aimed to describe five cases of rhinocerebral mucormycosis to review and possibly define diagnostic and surgical treatment guidelines. In all the patients, surgical debridement, systemic and local antifungal therapy, and oral rehabilitation using filling prostheses were performed. Results: None of the patients revealed recurrence of the infection, as confirmed by radiological and clinical long term follow up. Conclusion: Given the lethal nature of the disease, the authors underline the importance of early diagnosis and of a multidisciplinary approach in order to undertake correct surgical and medical treatments, while keeping the underlying disease under control.Keywords: Zygomycetes, Mucorales, rhinocerebral mucormycosis, immunocompromised patients, sinusitis, surgical debridement.
Related Journals
Anti-Cancer Agents in Medicinal Chemistry
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry
Current Bioactive Compounds
Current Cancer Drug Targets
Combinatorial Chemistry & High Throughput Screening
Current Cancer Therapy Reviews
Current Diabetes Reviews
Current Drug Safety
Current Drug Targets
Current Drug Therapy
Related Books
Quick Guide in History Taking and Physical Examination
Frontiers in Clinical Drug Research: Anti-Infectives
Osteoporosis, Osteoarthritis and Rheumatoid Arthritis: An Agonizing Skeletal Triad
Natural Products for Treatment of Skin and Soft Tissue Disorders
Common Pediatric Diseases: Current Challenges
Recent Advances in the Application of Marine Natural Products as Antimicrobial Agents
Advanced Pharmacy
Plant-derived Hepatoprotective Drugs
Cancer Genes
The Role of Chromenes in Drug Discovery and Development
34
3